CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

The hypothesis of this work is that the COVID 19 pandemic and the associated lockdowns are likely to modify the adherence to positive airway pressure (PAP) treatments among patients with sleep apnea. Identifying these patients and identifying adherence "trajectories" over time would help mobilize human and telemedicine resources on the patients most in need.

The primary objective of this study is to compare PAP adherence during lockdowns in 2020 with the corresponding weeks during 2019.

Inclusion Criteria:

• patient treated/monitored by the Adene group
• treated for sleep apnea syndrome (i.e., an initial apnoea hypopnea index (iAHI) ≥ 30/h or iAHI ≥ 15/h (and more than 10/h respiratory-effort-related arousal or cardio-metabolic/respiratory comorbidities) associated with symptoms from among sleepiness, tiredness, snoring, headaches, hypertension, reduced vigilance, libido disorders, nocturia, choking or suffocation during sleep, daytime tiredness)
• Positive airway pressure (PAP)-treated for at least 4 months before January 1, 2019
• continuous PAP during 2019
• continuous PAP during 2020
• acceptance of PAP telemonitoring with consent given for data collection and data anonymization

Exclusion Criteria:

• less than 360 daily PAP tele-monitored data per year for 2019
• less than 360 daily PAP tele-monitored data per year for 2020